Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

15.3K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
15.3K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

3.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.4K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

25
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
25
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

22
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
22
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

7.4K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.4K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

2.0K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Membrane Composition to Antimicrobial Strategies: Experimental and Computational Approaches to AMP Design and Selectivity.

Small (Weinheim an der Bergstrasse, Germany)·2025
Same author

Corrigendum to "Structural analysis of the NK-lysin-derived peptide NK-2 upon interaction with bacterial membrane mimetics consisting of phosphatidylethanolamine and phosphatidylglycerol" [BBA - Biomembr. 1866 (2024) 184267].

Biochimica et biophysica acta. Biomembranes·2025
Same author

Cytoadhesion of Plasmodium falciparum-Infected Red Blood Cells Changes the Expression of Cytokine-, Histone- and Antiviral Protein-Encoding Genes in Brain Endothelial Cells.

Molecular microbiology·2024
Same author

"Meet the IUPAB councilor"-Thomas Gutsmann.

Biophysical reviews·2024
Same author

A synthetic peptide mimic kills Candida albicans and synergistically prevents infection.

Nature communications·2024
Same author

Secretion of the fungal toxin candidalysin is dependent on conserved precursor peptide sequences.

Nature microbiology·2024

Related Experiment Video

Updated: Mar 26, 2026

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.5K

Interaction between antimicrobial peptides and mycobacteria.

Thomas Gutsmann1

  • 1Research Center Borstel, Leibniz-Center for Medicine and Biosciences, Priority Area Infections, Division of Biophysics, Parkallee 10, 23845 Borstel, Germany.

Biochimica Et Biophysica Acta
|February 7, 2016
PubMed
Summary

Antimicrobial peptides (AMPs) show promise for treating tuberculosis (TB) due to rising drug resistance and antibiotic side effects. AMPs can directly kill mycobacteria or boost immune responses against TB.

Keywords:
Antimicrobial peptideMembraneMode of actionMycobacteriaTuberculosis

More Related Videos

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.1K
Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

12.9K

Related Experiment Videos

Last Updated: Mar 26, 2026

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.5K
Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids
11:56

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

13.1K
Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization
10:13

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

12.9K

Area of Science:

  • Microbiology
  • Immunology
  • Pharmacology

Background:

  • Tuberculosis (TB) treatment faces challenges from multi-drug and extensively-drug resistant Mycobacterium tuberculosis strains.
  • Conventional antimycobacterial antibiotics often cause severe side effects, necessitating alternative therapeutic strategies.

Purpose of the Study:

  • To review the role of endogenous human antimicrobial peptides (AMPs) in tuberculosis (TB).
  • To summarize the antimycobacterial activity and molecular mechanisms of various AMPs.
  • To explore AMPs as potential therapeutic agents against TB.

Main Methods:

  • Literature review of studies on antimicrobial peptides and tuberculosis.
  • Analysis of the molecular modes of action of AMPs against mycobacteria.
  • Evaluation of AMPs' interaction with the mycobacterial cell envelope, including the mycomembrane and plasma membrane.

Main Results:

  • AMPs demonstrate direct antimycobacterial activity, often targeting the mycobacterial cell envelope.
  • The rigid mycomembrane of mycobacteria may reduce AMP efficacy compared to other bacteria.
  • AMPs can also function as immunomodulatory agents.

Conclusions:

  • Antimicrobial peptides (AMPs) represent a promising avenue for novel tuberculosis (TB) therapies, either alone or in combination with conventional antibiotics.
  • Challenges remain in delivering AMPs effectively, particularly during the latent phase of TB.
  • AMPs offer a potential solution to combat drug-resistant tuberculosis and mitigate side effects associated with current treatments.